Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Rank in Stocks #14758
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Share Price
$2.35
Market Cap
$394.12M
Change (1 day)
-1.07%
Change (1 year)
-64.75%
Country
TW
Trade Lumosa Therapeutics Co., Ltd. (6535)

Category

Stock split history for Lumosa Therapeutics Co., Ltd. (6535)
Lumosa Therapeutics Co., Ltd. stock (symbol: 6535) underwent a total of 0 stock splits.
The most recent stock split occurred on Sep 01, 2026.
One 6535 share bought prior to Sep 01, 2026 would equal to 0 6535 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH